The first-tier melt curve MC002 assay in combination with the second-tier P021–B1 MLPA assay showed feasibility and accuracy for SMA screening in a neonatal screening program to detect SMA patients, and can be used for early determination of an SMN2 copy number. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.